Better COVID-19 outcomes confirmed in TNF inhibitor usersOctober 22, 2021COVID-19 UpdatesGastroenterologyRheumatologyDermatology
Oteseconazole promising for recurrent yeast infectionsOctober 4, 2021Infectious DiseasesDermatologyWomen's Health
New virus causing ‘Alaskapox’ detected in two more casesSeptember 24, 2021Infectious DiseasesPediatricsDermatology
FDA approves topical ruxolitinib for atopic dermatitis, first JAK inhibitor for this indication in the U.S.September 21, 2021Dermatology
New guidance on preventing cutaneous SCC in solid organ transplant patientsSeptember 10, 2021DermatologyOncologyMixed Topics
Atopic dermatitis subtype worsens into midlife, predicting poor healthSeptember 10, 2021PediatricsDermatology
Ask about itch and joint pain in pediatric psoriasis patients, expert advisesSeptember 2, 2021PediatricsDermatology
